These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 17585539)

  • 1. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
    Gosney JR; Gosney MA; Lye M; Butt SA
    Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
    Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
    Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.
    Goh YW; Spagnolo DV; Platten M; Caterina P; Fisher C; Oliveira AM; Nascimento AG
    Histopathology; 2001 Nov; 39(5):514-24. PubMed ID: 11737310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
    Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
    Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
    Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
    Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
    Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
    Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
    Mjønes P; Sagatun L; Nordrum IS; Waldum HL
    J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
    Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
    Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
    Schürmann G; Betzler M; Buhr HJ
    Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
    Vyberg M; Horn T; Francis D; Askaa J
    Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoids of the gastrointestinal tract: importance of determining differentiation and proliferation markers].
    Jirásek T; Mandys V
    Cesk Patol; 2003 Apr; 39(2):47-53. PubMed ID: 12874899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
    Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
    Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretagogin is a novel marker for neuroendocrine differentiation.
    Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
    Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
    Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
    Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.